Idaho
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Idaho: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Idaho follows the federal precedent established in Myriad Genetics regarding the patent eligibility of isolated human genes. This aligns with a growing trend in other jurisdictions against the patenting of natural products absent additional inventive concepts.
Under Idaho law, as in federal law, isolated DNA sequences are not patentable unless they demonstrate significant alterations that constitute a new and non-naturally occurring composition of matter.
Held that patent claims must demonstrate a significant inventive step beyond mere isolation.
Established that patent claims related to natural products lack eligibility unless they involve transformative characteristics.
Emphasized public interest in preventing patent claims on foundational biological materials that are naturally occurring.
Idaho's approach broadly aligns with the federal interpretation that naturally occurring substances, including isolated genes, are not patentable. However, Idaho courts may adapt their analysis considering the state's agricultural and biological interests, leading to nuanced applications.
Students should be familiar with the impacts of Myriad on patent law as it relates to natural products and its implications in Idaho for the bar exam.